In the May/June 2015 issue of Advanced Ocular care, there was agreement among the experts on the significance of MGD. The highlights of the articles were summarized in an eblast. Please click here to read the thoughts of Walter O. Whitley, OD, MBA. Parag A Majmudar, MD, Casey Claypool, OD, Mile Brujic, OD, David Kading, OD, Cathleen M. McCabe, MD and Derek N. Cunningham, OD.1
An article released by Caroline A. Blackie, Od Phd, Alan N. Carlson, MD and Donalrd R. Korb, OD in Current Opinion in Ophthalmology summarized that “a single 12-minute vectored thermal pulsation treatment allows for reducing dry eye symptoms, improving meibomian gland function and other correlates of the ocular surface health.” Click here to download the paper. 1
An independent poster presented by Finis, et al titled “Evaluation of an Automated Thermodynamic Treatment (Lipiflow®) system for Meibomian Gland Dysfunction: A Prospective, Randomized, Observer-Masked Trial” concluded independently that a single LipiFlow® treatment is at least as effective as a fully compliant 3-month, twice-daily compress and lid margin hygiene regimen for MGD.1
TearScience® announced the launch of the LipiFlow® Lid Stabilizer Tape. The LipiFlow® Lid Stabilizer Tape was sent complimentary with every shipment sent in the month of August. The optional LipiFlow® Lid Stabilizer Tape is a precut medical tape, to be used as an accessory to stabilize the LipiFlow® Activator. TearScience® recommends the use of the LipiFlow® Lid Stabilizer Tape. Quantities of the tape can be ordered complimentary and is limited by comparable Activator purchase volume.
TearScience® announced the availability of electronic Indications For Use. Documentation (Indications For Use) is available by request from TearScience® for electronic delivery or printed material via mail. To receive login information to retrieve documentation online or the printed material, please contact TearScience® Customer Service at 1-919-459-4891 or email email@example.com.